SPBC16E9.10c Antibody

What is SPBC16E9.10c and why is it significant in fission yeast research?

SPBC16E9.10c is a gene identifier in Schizosaccharomyces pombe (fission yeast) that encodes a protein involved in cellular processes. While specific research on this particular gene is limited in the provided context, fission yeast serves as an important model organism for studying fundamental cellular mechanisms. The spindle pole body (SPB) in fission yeast undergoes duplication at the G1/S boundary, with maturation occurring later in the cell cycle . Understanding proteins like those encoded by SPBC16E9.10c can provide insights into conserved cellular mechanisms across eukaryotes. When developing antibodies against such proteins, researchers should consider the protein's localization, expression levels, and functional domains to ensure effective targeting.

What validation methods should be used to confirm SPBC16E9.10c antibody specificity?

To validate SPBC16E9.10c antibody specificity, researchers should implement multiple complementary approaches:

• Western blotting with controls: Use wild-type and SPBC16E9.10c knockout/knockdown strains to confirm the antibody recognizes the correct protein at the expected molecular weight.

• Immunoprecipitation followed by mass spectrometry: This method can confirm that the antibody captures the intended protein. Similar to techniques used for SpA5 antibody validation, where mass spectrometry was used to confirm antibody specificity after immunoprecipitation .

• Immunofluorescence microscopy: Compare staining patterns between wild-type and mutant strains, looking for expected subcellular localization.

• Competitive binding assays: Pre-incubation with purified recombinant protein should abolish specific signal.

• Cross-reactivity testing: Test against related proteins to ensure specificity, particularly important for antibodies targeting conserved domains.

The antibody affinity can be precisely measured using Biolayer Interferometry to determine KD values, similar to methods used for characterizing other research antibodies .

What are the most effective fixation methods for immunofluorescence using SPBC16E9.10c antibodies in S. pombe?

For immunofluorescence with SPBC16E9.10c antibodies in S. pombe, fixation method selection is critical and depends on antibody characteristics and protein properties:

Methanol fixation protocol:

• Grow cells to mid-log phase (OD600 0.5-0.8)

• Harvest and resuspend in cold methanol (-20°C) for 10 minutes

• Wash 3× with PEM buffer (100 mM PIPES, 1 mM EGTA, 1 mM MgSO4, pH 6.9)

• Digest cell wall with Zymolyase (1 mg/ml) for 30-60 minutes at 37°C

• Permeabilize with 1% Triton X-100 for 5 minutes

• Block with 5% BSA in PEMBAL buffer for 1 hour

Formaldehyde fixation alternative:

• Fix cells with 3.7% formaldehyde for 30 minutes

• Wash with PEM buffer

• Proceed with cell wall digestion and permeabilization

How can computational antibody design methods be applied to improve SPBC16E9.10c antibody affinity and specificity?

Computational antibody design can significantly enhance SPBC16E9.10c antibody development through a structured approach:

• Structure prediction: When crystallographic data is unavailable, use RosettaAntibody server to generate 3D structure models of the antibody targeting SPBC16E9.10c .

• Antigen-antibody docking: Employ two-step docking protocol as described in IsAb:

  • First, use ClusPro for global docking to identify potential binding poses

  • Follow with SnugDock for local refinement, allowing flexibility of interfacial side chains and CDR loops

• Hotspot identification: Perform in silico alanine scanning to identify key residues at the antibody-antigen interface that contribute most to binding energy .

• Computational affinity maturation:

  • Based on Rosetta scoring functions, design mutations to improve binding affinity

  • Focus modifications on CDR loops while maintaining antibody stability

  • Rank mutated antibodies by predicted improvement in binding affinity and stability

• Iterative validation: Experimentally test the top candidates and use feedback to refine computational models.

These computational methods can reduce experimental screening time and costs while potentially producing antibodies with nanomolar affinity, similar to what has been achieved with other antibodies like Abs-9 (KD value of 1.959 × 10^-9 M) .

What strategies can resolve cross-reactivity issues with SPBC16E9.10c antibodies in closely related yeast species?

Cross-reactivity with related proteins in different yeast species presents a significant challenge for SPBC16E9.10c antibodies. To address this:

Epitope-focused approach:

• Perform sequence alignment of SPBC16E9.10c with homologs from related species

• Identify unique regions with low sequence conservation

• Generate antibodies against these unique epitopes

• Use peptide competition assays to confirm epitope specificity

Advanced purification strategy:

• Pre-absorb antibodies with lysates from related species

• Perform affinity purification using recombinant SPBC16E9.10c protein

• Elute with low pH buffer (pH 2.8) and immediately neutralize

• Test purified antibody against panels of related proteins

Negative control validation matrix:

The specific antibody characterization should follow similar rigorous validation approaches used for other research antibodies, ensuring that binding is specific to the intended target protein .

How can high-throughput single-cell sequencing approaches be adapted for improved SPBC16E9.10c antibody development?

High-throughput single-cell sequencing technologies offer powerful approaches for next-generation SPBC16E9.10c antibody development:

Integrated B-cell screening protocol:

• Immunize animal models with purified SPBC16E9.10c protein

• Isolate memory B cells using fluorescence-activated cell sorting (FACS)

• Perform high-throughput single-cell RNA and VDJ sequencing to identify antigen-binding clonotypes, similar to methods used for identifying S. aureus antibodies

• Select top candidates based on sequence characteristics and expression levels

• Express and characterize candidate antibodies

Data analysis pipeline:

• Process raw sequencing data to identify full-length antibody sequences

• Cluster sequences into clonotypes based on CDR3 similarity

• Prioritize expanded clonotypes that indicate strong antigen-specific responses

• Apply computational filters to select candidates with optimal properties

• Use structural prediction to further refine selection

This approach can rapidly identify hundreds of antigen-binding candidates from which the most promising antibodies can be selected. In previous studies, this approach successfully identified 676 antigen-binding IgG1+ clonotypes, from which highly effective antibodies were developed .

What are the most common causes of weak or non-specific signals when using SPBC16E9.10c antibodies in western blots?

When troubleshooting weak or non-specific signals with SPBC16E9.10c antibodies in western blots, consider these methodological solutions:

Common causes and solutions:

• Low protein expression levels:

  • Enrich the target protein via immunoprecipitation before western blotting

  • Use more sensitive detection methods (e.g., chemiluminescent substrates with longer exposure times)

  • Consider cell cycle synchronization if protein expression is cell cycle-dependent, particularly since many S. pombe proteins show cell cycle regulation

• Inadequate protein extraction:

  • For yeast cells, use glass bead lysis in the presence of protease inhibitors

  • Include detergents suitable for membrane proteins if SPBC16E9.10c is membrane-associated

  • Consider specialized extraction buffers containing 8M urea for difficult-to-extract proteins

• Inefficient protein transfer:

  • Optimize transfer conditions (time, voltage, buffer composition)

  • Use PVDF membranes for proteins that are difficult to transfer

  • Consider semi-dry transfer systems for improved efficiency

• Cross-reactivity issues:

  • Increase blocking stringency (5% BSA or milk, overnight at 4°C)

  • Include competing proteins from other species

  • Use monovalent Fab fragments instead of whole IgG antibodies if protein A-like activity is suspected, similar to strategies used when working with S. aureus proteins

• Primary antibody concentration optimization:

  • Test dilution series (1:100 to 1:10,000)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Consider using antibody enhancer solutions

Systematic optimization of these parameters can significantly improve signal quality and specificity.

How can researchers distinguish between non-specific binding and true low-abundance targets when using SPBC16E9.10c antibodies?

Distinguishing between non-specific binding and true low-abundance targets requires a comprehensive validation approach:

Definitive validation strategy:

• Genetic controls:

  • Compare wild-type to SPBC16E9.10c deletion strains

  • Use strains with tagged versions of SPBC16E9.10c (e.g., GFP, TAP, HA)

  • Employ inducible expression systems to modulate protein levels

• Biochemical validation:

  • Perform peptide competition assays using the immunizing peptide

  • Pre-absorb antibody with recombinant SPBC16E9.10c protein

  • Conduct immunoprecipitation followed by mass spectrometry to identify all bound proteins

• Signal enhancement methods for low-abundance targets:

  • Use tyramide signal amplification (TSA)

  • Employ proximity ligation assay (PLA) for increased sensitivity

  • Consider protein concentration methods before analysis

• Quantitative assessment:

  • Measure signal-to-noise ratios across multiple experiments

  • Compare signal intensity patterns across different extraction conditions

  • Analyze correlation between antibody signal and known biological variables

Similar approaches have been successfully applied to validate other antibodies, such as the validation of Abs-9 specificity for SpA5 using mass spectrometry after immunoprecipitation .

What are effective strategies for optimizing immunoprecipitation protocols with SPBC16E9.10c antibodies for protein interaction studies?

Optimizing immunoprecipitation (IP) protocols for SPBC16E9.10c protein interaction studies requires careful consideration of multiple parameters:

Advanced IP optimization protocol:

• Lysis buffer optimization:

  • Test different detergents (NP-40, Triton X-100, CHAPS) at varying concentrations (0.1-1%)

  • Adjust salt concentration (150-500 mM NaCl) to balance specificity and maintenance of interactions

  • Include appropriate protease and phosphatase inhibitors

• Antibody coupling approaches:

  • Direct coupling to solid support (e.g., NHS-activated resin)

  • Protein A/G beads with covalent crosslinking to prevent antibody leaching

  • Magnetic beads for gentler handling and reduced background

• IP conditions optimization:

  • Compare different antibody-to-lysate ratios

  • Test various incubation times (2 hours vs. overnight) and temperatures (4°C vs. room temperature)

  • Evaluate pre-clearing strategies to reduce non-specific binding

• Washing stringency gradient:

  • Implement sequential washes with increasing stringency

  • Test detergent concentration effects on signal retention

  • Optimize number of washes to balance signal and background

• Elution method comparison:

  • Acidic elution (glycine buffer, pH 2.5)

  • Competitive elution with excess antigen peptide

  • SDS elution for complete recovery

• Controls for validation:

  • Isotype control antibodies

  • Pre-immune serum controls

  • IP from SPBC16E9.10c knockout strains

For interaction studies, consider crosslinking approaches (e.g., DSP, formaldehyde) to capture transient interactions before cell lysis. This approach has been successfully used in other studies to identify specific interactions, such as in the validation of SpA5 as the specific antigen for Abs-9 .

How can SPBC16E9.10c antibodies be used to study protein dynamics during the cell cycle in S. pombe?

SPBC16E9.10c antibodies can be powerful tools for studying protein dynamics throughout the S. pombe cell cycle:

Integrated cell cycle analysis approach:

• Synchronization methods optimization:

  • Nitrogen starvation/release for G1 synchronization

  • Hydroxyurea block for S-phase arrest

  • Temperature-sensitive cdc mutant strains for specific cell cycle points

  • Lactose gradient centrifugation for size-based separation

  These methods have been successfully used to study SPB duplication in S. pombe, revealing that duplication occurs at the G1/S boundary .

• Time-course experimental design:

  • Collect samples at defined intervals after synchronization release

  • Process for both western blot and immunofluorescence analyses

  • Correlate with cell cycle markers (DNA content, septation index)

• Quantitative microscopy methods:

  • Use automated image acquisition platforms

  • Implement cell segmentation algorithms

  • Quantify signal intensity, localization changes, and protein complexes

  • Track single cells through time-lapse microscopy

• Protein modification analysis:

  • Combine with phospho-specific antibodies to track post-translational modifications

  • Use 2D gel electrophoresis to separate modified forms

  • Apply SILAC or TMT labeling for mass spectrometry quantification

• Co-localization studies:

  • Pair with antibodies against known cell cycle markers

  • Implement multi-color imaging to track relative localizations

  • Use super-resolution microscopy for detailed spatial analysis

This approach allows researchers to correlate SPBC16E9.10c dynamics with key cell cycle transitions, similar to how SPB duplication and maturation have been mapped to specific cell cycle phases in S. pombe .

What approaches can integrate SPBC16E9.10c antibody data with other omics datasets for systems-level understanding?

Integrating SPBC16E9.10c antibody data with multi-omics approaches enables comprehensive systems biology insights:

Multi-dimensional data integration framework:

• Proteomic integration:

  • Combine immunoprecipitation with mass spectrometry (IP-MS)

  • Correlate antibody-based quantification with global proteome changes

  • Map post-translational modifications through phospho-proteomics

  • Compare protein abundance with immunoblotting results for validation

• Transcriptomic correlation:

  • Integrate RNA-seq data to correlate transcript and protein levels

  • Examine discordance for insights into post-transcriptional regulation

  • Apply single-cell RNA-seq approaches for cell-to-cell variation analysis

  • High-throughput sequencing approaches can provide valuable complementary data, similar to how B-cell sequencing has been used to identify antibody sequences

• Genomic data linking:

  • Connect ChIP-seq data if SPBC16E9.10c has DNA-binding properties

  • Relate genetic interaction networks to observed protein interactions

  • Incorporate mutant phenotype data from genome-wide screens

• Visualization and analysis tools:

  • Network analysis tools (Cytoscape, STRING)

  • Correlation analysis across datasets

  • Machine learning approaches for pattern identification

  • Pathway enrichment analysis

• Temporal dimension integration:

  • Time-course experiments across multiple data types

  • Differential equation modeling of dynamic processes

  • Identification of causal relationships through perturbation studies

Data integration matrix:

This multi-dimensional approach provides a systems-level understanding of SPBC16E9.10c function and regulation in cellular processes.

How can structural biology approaches be combined with SPBC16E9.10c antibodies for epitope mapping and structure-function studies?

Integrating structural biology with SPBC16E9.10c antibodies enables precise epitope mapping and deeper structure-function insights:

Advanced structural biology integration approach:

• X-ray crystallography of antibody-antigen complexes:

  • Express and purify recombinant SPBC16E9.10c protein domains

  • Generate Fab fragments from SPBC16E9.10c antibodies

  • Co-crystallize Fab-antigen complexes

  • Solve structure to identify atomic-level interactions at the binding interface

• Cryo-EM analysis:

  • Particularly valuable for larger protein complexes

  • Use antibodies to identify specific components within complexes

  • Apply single-particle analysis for structural determination

  • Combine with gold-labeled antibodies for localization studies

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

  • Compare deuterium uptake patterns with and without antibody binding

  • Identify protected regions indicating antibody epitopes

  • Map results onto predicted protein structures

  • Correlate with functional domains

• Computational epitope mapping:

  • Implement molecular docking approaches as described in antibody design protocols

  • Use in silico alanine scanning to predict critical binding residues

  • Apply Alphafold2 for structure prediction when crystallographic data is unavailable

  • Combine with molecular dynamics simulations to assess flexibility

• Mutational analysis guided by structural data:

  • Design targeted mutations based on structural predictions

  • Evaluate effects on antibody binding

  • Correlate with functional consequences

  • Create structure-function maps of the protein

This integrated approach has been successfully applied in other antibody research, such as the epitope prediction and validation for Abs-9 based on Alphafold2 and molecular docking methods .

How can SPBC16E9.10c antibodies be adapted for super-resolution microscopy to study spatial organization in S. pombe?

Adapting SPBC16E9.10c antibodies for super-resolution microscopy requires specialized approaches to overcome technical challenges:

Super-resolution optimization protocol:

• Antibody fragmentation and labeling:

  • Generate Fab or F(ab')2 fragments for reduced size and better penetration

  • Site-specific labeling with small fluorophores (Alexa Fluor 647, Cy5.5, Atto dyes)

  • Optimize dye-to-protein ratio (typically 1-2 dyes per antibody)

  • Purify labeled antibodies by size exclusion chromatography

• Sample preparation optimization:

  • Test fixation methods for structural preservation (2-4% paraformaldehyde with 0.1% glutaraldehyde)

  • Evaluate permeabilization approaches for antibody accessibility

  • Consider expansion microscopy for physical enlargement of samples

  • Implement clearing techniques to reduce background autofluorescence

• Imaging technique selection based on research questions:

  • STORM/PALM for single-molecule localization (10-20 nm resolution)

  • STED for live-cell compatibility (30-70 nm resolution)

  • SIM for larger field of view with modest resolution gain (100-120 nm)

  • ExM for enhanced resolution with standard confocal equipment

• Colocalization studies with organelle markers:

  • Spindle pole body markers (relevant given the SPB research context )

  • Nuclear envelope components

  • Cytoskeletal elements

  • Cell division machinery

• Quantitative analysis approaches:

  • Cluster analysis algorithms

  • Nearest neighbor measurements

  • Ripley's K-function for spatial distribution assessment

  • Coordinate-based colocalization analysis

This methodology enables visualization of SPBC16E9.10c spatial organization at nanoscale resolution, revealing previously undetectable structural details and protein interactions.

What are the best approaches for using SPBC16E9.10c antibodies in chromatin immunoprecipitation studies?

Optimizing chromatin immunoprecipitation (ChIP) with SPBC16E9.10c antibodies requires specialized protocols for yeast cells:

S. pombe-specific ChIP optimization strategy:

• Crosslinking optimization:

  • Compare formaldehyde concentrations (1-3%) and times (5-30 min)

  • Evaluate dual crosslinking with DSG followed by formaldehyde

  • Test native ChIP approaches if the protein-DNA interaction is strong

  • Include glycine quenching (125 mM final concentration)

• Chromatin preparation:

  • Mechanical cell disruption with glass beads for efficient yeast cell lysis

  • Sonication optimization to achieve 200-500 bp fragments (test 5-15 cycles)

  • Enzymatic fragmentation alternatives (MNase digestion)

  • Verify fragment size distribution by agarose gel electrophoresis

• Immunoprecipitation conditions:

  • Antibody titration to determine optimal concentration

  • Pre-clearing with protein A/G beads to reduce background

  • Extended incubation times (overnight at 4°C with rotation)

  • Sequential ChIP for co-occupancy studies

• Washing stringency optimization:

  • Implement sequential washes with increasing salt concentrations

  • Include detergent (0.1% SDS, 1% Triton X-100) in wash buffers

  • Optimize number of washes to balance signal retention and background reduction

  • Consider LiCl washes for removing RNA-mediated interactions

• Controls and validation:

  • Input DNA (pre-immunoprecipitation sample)

  • Non-specific IgG control

  • ChIP in deletion/knockout strains

  • Spike-in normalization with exogenous DNA

• Analysis approaches:

  • ChIP-qPCR for targeted validation

  • ChIP-seq for genome-wide binding profiles

  • ChIP-exo or ChIP-nexus for higher resolution

  • CUT&RUN as a potentially more sensitive alternative

These approaches can be used to study potential DNA interactions of SPBC16E9.10c, which might be particularly relevant if it has roles in genome stability or transcriptional regulation.

How can computational modeling improve the understanding of SPBC16E9.10c structural dynamics when combined with antibody epitope data?

Integrating computational modeling with antibody epitope data provides powerful insights into SPBC16E9.10c structure and dynamics:

Integrated computational-experimental approach:

• Structure prediction and refinement:

  • Generate initial models using AlphaFold2 or RosettaFold

  • Refine structures based on antibody epitope constraints

  • Incorporate experimental data as distance restraints

  • Validate models with cross-linking mass spectrometry data

• Epitope mapping integration:

  • Use antibody binding data to identify surface-exposed regions

  • Map conservation patterns onto structural models

  • Identify potential functional domains based on epitope accessibility

  • Similar approaches have been used for epitope prediction in other antibody research

• Molecular dynamics simulations:

  • Run long-timescale simulations to explore conformational flexibility

  • Analyze protein dynamics in different cellular environments

  • Identify potential allosteric sites and communication pathways

  • Assess effects of post-translational modifications on structure

• Antibody-guided structure validation:

  • Compare predicted antibody binding sites with experimental data

  • Use antibody accessibility data to validate structural models

  • Identify discrepancies that may indicate alternative conformations

  • Refine models based on feedback between experimental and computational results

• Functional prediction from structure:

  • Identify potential interaction surfaces

  • Predict ligand binding pockets

  • Map known mutations onto structure to understand functional impacts

  • Guide design of new antibodies targeting specific functional domains

This integrated approach provides a dynamic understanding of SPBC16E9.10c structure and function that static methods alone cannot achieve. The computational modeling can follow similar approaches to those used in the IsAb antibody design protocol, which uses structural prediction and molecular docking for optimal antibody design .